Creative Biolabs, a provider of glycobiology solutions, has announced enhanced capabilities for custom oligosaccharide synthesis and glycan characterization to support drug discovery and biomedical research. The integrated platform combines chemical, enzymatic, and chemoenzymatic synthesis with advanced analytical tools such as mass spectrometry (MS), high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR) to deliver structurally validated glycans.
Oligosaccharides play critical roles in cell signaling, immune regulation, pathogen-host interactions, and disease progression, making them valuable for therapeutic, vaccine, and diagnostic research. However, their structural complexity complicates synthesis, purification, and characterization. Creative Biolabs addresses these challenges by offering custom synthesis of high-purity oligosaccharides, complex glycans, tumor-associated carbohydrate antigens (TACAs), and functionalized carbohydrate derivatives, coupled with rigorous analytical validation.
"The structural complexity of oligosaccharides continues to present significant challenges for researchers developing next-generation therapeutics," said a scientist from Creative Biolabs. "By integrating custom synthesis with comprehensive analytical characterization, we help researchers obtain structurally validated glycans that support reliable downstream studies and accelerate scientific discovery."
In one recent project, researchers required a complex glycan structure not readily available through standard commercial sources. Integrated synthesis and analytical characterization helped support downstream structural confirmation, highlighting the quality and technical support provided. The company's application-oriented carbohydrate design serves structural biology, glycoprotein research, biomarker discovery, immunology, targeted drug delivery, and therapeutic development.
By combining custom carbohydrate synthesis with rigorous analytical characterization under one integrated platform, Creative Biolabs helps researchers reduce technical risks, improve experimental reproducibility, and accelerate scientific innovation. Researchers can explore customized oligosaccharide synthesis and glycan characterization options through Creative Biolabs' glycobiology platform at https://www.creative-biolabs.com/glycoprotein/.
